logo for ImmunoGen

ImmunoGen

Business Services · Massachusetts, United States · 277 Employees

View Company Info for Free

About

Headquarters

830 Winter St, Waltham, Massachusetts, 02451, U...

Phone Number

(781) 895-0600

Revenue

$287.6 Million

Stock Symbol

IMGN

Industry

Medical Testing & Clinical Laboratories Healthcare

Highlights

$1B

Total Funding Amount

$175M

Most Recent Funding Amount

13

Number of Funding Rounds

Who is ImmunoGen

ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its ant ibody-drug conjugate (ADC) technology. The companys product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham,...Read more

ImmunoGen's Social MediaPopular SearchesImmunogen IncImmunogenImmunogen LLCImmugen Corp830 Winter Street LLCSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: IMGNShow more

ImmunoGen Org Chart

Mark Enyedy

President & Chief Executive Officer

PhoneEmail
Audrey Bergan

Senior Vice President and Chief Human Resourc...

PhoneEmail
Renee Farrell

Chief Technology Officer

PhoneEmail

PhoneEmail

Is ImmunoGen your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to ImmunoGen

  1. 123
    $38.3M

    1

  2. 160
    $6.1M

    2

  3. 339
    $41.8M

    3

  4. 587
    $38.2M

    4

  5. 103
    $18.9M

    5

  6. 79
    $11.7M

    6

See more similar companies
Illustration of an envelope

ImmunoGen Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateApr 06, 2023
RoundDebt
Amount$175M
InvestorsPharmakon Advisors
Funding DateOct 12, 2020
RoundShare Placement
Amount$54.8M
Investors
Funding DateJan 27, 2020
RoundStock Issuance/Offering
Amount$104.2M
InvestorsUndisclosed
See More

$1B

Total Funding Amount

$175M

Most Recent Funding Amount

13

Number of Funding Rounds

Acquisitions & Subsidiaries

Jul 18, 2022

SkinMedica

Jul 18, 2022

SkinMedica

Dec 29, 2021

Allergan

Nov 17, 2021

Allergan Pharmaceuticals Taiwan

Nov 17, 2021

Allergan

Nov 17, 2021

Allergan Limited

See More Acquisitions & Subsidiaries

ImmunoGen Tech Stack

A closer look at the technologies used by ImmunoGen

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Most Recent Scoops

May 30 2024
Event
Events
Apr 5 2024
Left Company
Executive Move
Dec 10 2023
Event
Events
Nov 30 2023
Mergers & Acquisitions (M&A)
See more scoops

ImmunoGen News & Media

Read more news

Frequently Asked Questions Regarding ImmunoGen

Where is ImmunoGen located?
ImmunoGen's headquarters are located at 830 Winter St, Waltham, Massachusetts, 02451, United States
What is ImmunoGen's phone number?
ImmunoGen's phone number is (781) 895-0600
What is ImmunoGen's stock symbol?
ImmunoGen's stock symbol is IMGN
What is ImmunoGen's official website?
ImmunoGen's official website is www.immunogen.com
What is ImmunoGen's Revenue?
ImmunoGen's revenue is $287.6 Million
What is ImmunoGen's SIC code?
ImmunoGen's SIC: 87,873
What is ImmunoGen's NAICS code?
ImmunoGen's NAICS: 54,541
How many employees does ImmunoGen have?
ImmunoGen has 277 employees
What industry does ImmunoGen belong to?
ImmunoGen is in the industry of: Medical Testing & Clinical Laboratories, Healthcare
What is ImmunoGen competition?
ImmunoGen top competitors include: Mersana Therapeutics, Celldex Therapeutics, MacroGenics, Mirati Therapeutics
What companies has ImmunoGen acquired?
ImmunoGen has acquired the companies: SkinMedica, SkinMedica, Allergan, Allergan Pharmaceuticals Taiwan
What technology does ImmunoGen use?
Some of the popular technologies that ImmunoGen uses are: Facebook Web Custom Audiences, Facebook Pixel, Gravity, WordPress.org
Who is the CEO of ImmunoGen?
ImmunoGen's CEO is Mark Enyedy
Who is the CFO of ImmunoGen?
ImmunoGen's CFO is Lauren White
Who is the CTO of ImmunoGen?
ImmunoGen's CTO is Renee Farrell
How do I contact ImmunoGen?
ImmunoGen contact info: Phone number: (781) 895-0600 Website: www.immunogen.com
What does ImmunoGen do?

ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The companys product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IM... GN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham,...Read More

What are ImmunoGen social media links?
ImmunoGen Linkedin page ImmunoGen Twitter page ImmunoGen Facebook page
How much funding has ImmunoGen raised to date?
ImmunoGen has raised $1 Billion in 13 funding rounds
When was the last funding round for ImmunoGen?
ImmunoGen closed its last funding round on Apr 06, 2023 with the amount of $175 Million
Who invested in ImmunoGen?
ImmunoGen has 13 investors including Undisclosed, sanofi-aventis, Ziff Asset Management and U.S. Food and Drug Administration.
Is ImmunoGen a public company?
Yes, ImmunoGen is a public company and is traded under the symbol IMGN
See more information about ImmunoGen

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.